We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Eyenovia Inc | NASDAQ:EYEN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.0663 | 13.42% | 0.5603 | 0.55 | 0.5619 | 11,302 | 10:09:36 |
| | |
PER
SHARE |
| |
TOTAL
|
| ||||||
Offering price
|
| | | $ | 0.40 | | | | | $ | 5,140,000 | | |
Placement agent’s fees(1)
|
| | | $ | 0.028 | | | | | $ | 359,800 | | |
Proceeds to Eyenovia, Inc. before expenses
|
| | | $ | 0.372 | | | | | $ | 4,780,200 | | |
| | | | | S-1 | | | |
| | | | | S-2 | | | |
| | | | | S-6 | | | |
| | | | | S-8 | | | |
| | | | | S-10 | | | |
| | | | | S-12 | | | |
| | | | | S-13 | | | |
| | | | | S-14 | | | |
| | | | | S-17 | | | |
| | | | | S-17 | | | |
| | | | | S-17 | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 10 | | | |
| | | | | 11 | | | |
| | | | | 13 | | | |
| | | | | 14 | | | |
| | | | | 16 | | | |
| | | | | 22 | | | |
| | | | | 23 | | | |
| | | | | 24 | | | |
| | | | | 26 | | | |
| | | | | 28 | | | |
| | | | | 29 | | | |
| | | | | 29 | | | |
| | | | | 29 | | |
|
Offering price per share of Common Stock
|
| | | $ | 0.40 | | |
|
Historical net tangible book deficit per share as of June 30, 2024
|
| | | $ | (0.15) | | |
|
Pro forma increase in net tangible book value per share
|
| | | $ | 0.10 | | |
|
Pro forma net tangible book deficit per share as of June 30, 2024
|
| | | $ | (0.05) | | |
|
Increase per share attributable to investors in this offering
|
| | | $ | 0.06 | | |
|
Pro forma as adjusted net tangible book value per share after this offering
|
| | | $ | 0.01 | | |
|
Dilution per share to investors in this offering
|
| | | $ | 0.39 | | |
| | |
PER SHARE
|
| |
TOTAL
|
| ||||||
Offering price
|
| | | $ | 0.40 | | | | | $ | 5,140,000 | | |
Placement Agent’s fees
|
| | | $ | 0.028 | | | | | $ | 359,800 | | |
Proceeds to Eyenovia, Inc. before expenses
|
| | | $ | 0.372 | | | | | $ | 4,780,200 | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 10 | | | |
| | | | 11 | | | |
| | | | 13 | | | |
| | | | 14 | | | |
| | | | 16 | | | |
| | | | 22 | | | |
| | | | 23 | | | |
| | | | 24 | | | |
| | | | 26 | | | |
| | | | 28 | | | |
| | | | 29 | | | |
| | | | 29 | | | |
| | | | 29 | | |
1 Year Eyenovia Chart |
1 Month Eyenovia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions